| Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer |
|
Results from the Eastern Cooperative Oncology Group Study E3200. Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB J Clin. Oncol. 2007 Apr 20;25(12):1539-44.
|